Amgen Agrees To $200M Settlement Of Antitrust Suit
Pharmaceutical giant Amgen Inc. has agreed to pay $200 million to settle antitrust claims brought by Ortho Biotech Products LP involving Amgen's anemia treatments....To view the full article, register now.
Already a subscriber? Click here to view full article